Cancer Detection and Diagnosis Research in Louisiana
Cancer Detection and Diagnosis Research (93.394) awarded $6.7 million to recipients in Louisiana in 7 grants from fiscal 2021 to 2025, 0.3% of the program's national total. The Administrators of Tulane Educational Fund received the most, $2.7 million.
- Awarded in Louisiana$6.7 million
- Awards7
- Share of the program0.3%
- Rank among states37th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $1.4 million |
| FY 2022 | 5 | $1.5 million |
| FY 2023 | 4 | $1.5 million |
| FY 2024 | 4 | $1.3 million |
| FY 2025 | 3 | $1.0 million |
Recipients in Louisiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Administrators of Tulane Educational Fund | Colleges and universities | 2 | $2.7 million |
| Pennington Biomedical Research Center | Colleges and universities | 2 | $2.7 million |
| Louisiana State University Health Sciences Center New Orleans | Colleges and universities | 3 | $1.3 million |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Louisiana?
$6.7 million from fiscal 2021 to 2025, across 7 awards. Louisiana ranks 37th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Louisiana?
The largest recipient is The Administrators of Tulane Educational Fund, with $2.7 million in 2 awards. Next are Pennington Biomedical Research Center and Louisiana State University Health Sciences Center New Orleans.
Can organizations in Louisiana apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Louisiana
- Grants to States for Medicaid
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Highway Planning and Construction
- Education Stabilization Fund
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Broadband Equity, Access, and Deployment Program